The FDA continues its efforts to curb the proliferation of products claiming to contain cannabidiol and marketed as treatments for acute and chronic pain.
The agency’s concern has most recently taken the form of a joint warning letter with the Federal Trade Commission to Rooted Apothecary LLC, of Naples, Fla., for illegally selling unapproved products containing CBD online with unsubstantiated claims that the products treat teething pain and earaches in infants, among other